window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 26, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Development

  • Clinical Trials,Drug Development,Rare Diseases

    Cereno taps global CRO for next big step in pulmonary hypertension drug trial

    Selection of CRO marks key milestone in advancing CS1 as [...]

    July 7, 2025
  • Biologics & Biosimilars,Clinical Trials,Drug Development,Rare Diseases

    Eleva doses first volunteers with new therapy targeting rare kidney disease

    Dosing of CPV-104 in healthy volunteers marks key milestone in [...]

    July 7, 2025
  • Artificial Intelligence,Clinical Development,Drug Development,Regulatory Affairs,Technology and platforms

    Why generic AI fails pharma and how purpose-built AI is revolutionizing drug development

    Artificial intelligence (AI) is transforming many industries, but in pharma, [...]

    July 3, 2025
  • Clinical Development,Drug Development,Precision medicine,Rare Diseases,Technology and platforms

    Rewind Therapeutics strengthens Scientific Advisory Board with leading neurology experts as it advances remyelination therapy

    Appointments enhance clinical expertise as GPR17 modulator progresses toward trials [...]

    July 2, 2025
  • CDMOs & Manufacturing,Drug Development,Partnerships & Funding,Rare Diseases

    Shionogi and BioVersys agree €498M licensing deal for NTM drug candidates

    Deal gives Shionogi access to BioVersys’ BV500 program targeting serious [...]

    July 2, 2025
  • Artificial Intelligence,Drug Development,Technology and platforms

    Optibrium and TalTech launch EU-funded PhD to advance sustainable drug discovery

    Partnership aims to boost predictive metabolism models using machine learning [...]

    July 2, 2025
  • CDMOs & Manufacturing,Drug Development,Regulatory Affairs,Technology and platforms

    Thermo Fisher upgrades charged aerosol detection tech to improve complex drug analysis

    Thermo Fisher Scientific has introduced a new version of its [...]

    July 2, 2025
  • Biologics & Biosimilars,Clinical Development,Drug Development,Rare Diseases

    Takeda’s mezagitamab shows rapid, durable platelet response in Phase 2 ITP trial

    Data presented at ISTH 2025 highlight potential for improved outcomes [...]

    July 3, 2025
  • Artificial Intelligence,Clinical Development,Drug Development,Market Access & Commercialization,Partnerships & Funding,Patient Centricity

    Lisata and GATC expand partnership to develop AI-discovered treatment for opioid use disorder

    New alliance targets early 2026 for first-in-human trial of non-opioid [...]

    July 1, 2025
  • Artificial Intelligence,Drug Development,Partnerships & Funding

    Oxeltis and MFI join forces as $12.8 BN in silico drug discovery market accelerates

    Contract research firm Oxeltis and computational chemistry company Molecular Forecaster [...]

    June 30, 2025
Previous181920Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Bio-Sourcing and Tiny Cargo partner to develop oral monoclonal antibodies using milk exosomes
    Categories: Biotech, Drug Delivery & Formulation, Drug Development, Partnerships & Funding, Pharmaceuticals and therapeutics
  • Levicept reports Phase 2 osteoarthritis data in The Lancet showing pain reduction with LEVI-04
    Categories: Clinical Trials, Pharmaceuticals and therapeutics, Research & Development
  • Nuclera launches GPCR nanodisc panel to address membrane protein bottleneck in drug discovery
    Categories: Biotech, Drug discovery, Research & Development, Technology and platforms
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top